Tag: Icade
Icade: In sharp decline, the analysis of a broker
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Icade: in sharp decline, the analysis of a broker – 03/17/2023 at 16:40
(CercleFinance.com) – Icade sells more than 3% in Paris, while Invest Securities maintains its buy rating on the stock, with a price target reduced from 57.2 to 55.1 euros. The…
Icade: in sharp decline, the analysis of a broker
(CercleFinance.com) – Icade sells more than 3% in Paris, while Invest Securities maintains its buy rating on the stock, with a price target reduced from 57.2 to 55.1 euros. The…
Icade climbs after the announcements!
By Claude Leguilloux Posted on 03/14/2023 at 11:10 a.m. (Boursier.com) — Icade climbed 6% to…
Icade: Oddo confirms its advice on the share
(CercleFinance.com) – Oddo maintains its ‘outperformance’ rating for Icade shares, with an unchanged target price of 61 euros. The analysis office reports that Icade, the minority shareholders of Icade Santé…
Icade: Oddo bets on a small revolution for the property company Icade and its health subsidiary
(BFM Bourse) – The research office Oddo has radically changed its opinion on the action, seeing several events which could occur in the short term and which would be likely…
Icade: Invest Securities lowers its target
(CercleFinance.com) – Invest Securities maintains its advice to buy Icade shares, with a price target reduced from 60 to 57.2 euros. ‘No solution in terms of liquidity for Icade Santé…
Icade: 7% increase in the CFNC in 2022 – 02/20/2023 at 09:35
(CercleFinance.com) – Icade publishes net current cash flow (NCCF) for 2022 up 7% to approximately 417 million euros (i.e. +5.9% to 5.50 euros per share),’ above guidance’, for IFRS revenue…
Icade will change its Chief Executive Officer and forecasts stable or slightly higher profits – 02/20/2023 at 09:51
(AOF) – Icade has unveiled a current net cash flow for 2022 up 7% to 417 million euros. Based on the number of shares, it rose 5.9% to 5.50 euros.…
Icade will “probably not” list its health subsidiary on the stock market
Icade, real estate subsidiary of the Caisse des dépôts et consignations (CDC), will “probably not” list its health subsidiary on the stock market, and is instead considering other means of…
Icade: 7% increase in CFNC in 2022
(CercleFinance.com) – Icade publishes net current cash flow (NCCF) for 2022 up 7% to approximately 417 million euros (i.e. +5.9% to 5.50 euros per share),’ above guidance’, for IFRS revenue…
Icade confirms the good momentum of its activities in 2022 – 01/04/2023 at 10:29
(AOF) – Following the announcements made during the Investor Day on November 28, Icade confirmed the very good momentum of its activities at the end of 2022 with two new…